HRP20230677T1 - Kombinacija ibuprofena i tramadola za ublažavanje boli - Google Patents

Kombinacija ibuprofena i tramadola za ublažavanje boli Download PDF

Info

Publication number
HRP20230677T1
HRP20230677T1 HRP20230677TT HRP20230677T HRP20230677T1 HR P20230677 T1 HRP20230677 T1 HR P20230677T1 HR P20230677T T HRP20230677T T HR P20230677TT HR P20230677 T HRP20230677 T HR P20230677T HR P20230677 T1 HRP20230677 T1 HR P20230677T1
Authority
HR
Croatia
Prior art keywords
combination
ibuprofen
pharmaceutically acceptable
use according
tramadol
Prior art date
Application number
HRP20230677TT
Other languages
English (en)
Croatian (hr)
Inventor
Antonio PORTOLÉS PÉREZ
Luis Narciso SANTÉ SERNA
María del Rosario SALAS BUTRÓN
Emilio VARGAS CASTRILLÓN
Carlos CALANDRIA PÉREZ
Raquel HORCAJADA CÓRDOBA
Ángel José MUÑOZ RUIZ
Marta Vicario De La Torre
Nuria SANZ MENÉNDEZ
Antonia GÓMEZ CALVO
Jose Angel SÁNCHEZ GARCÍA
Ester DUART GONZALEZ
Fernando García Alonso
Original Assignee
Farmalider, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider, S.A. filed Critical Farmalider, S.A.
Publication of HRP20230677T1 publication Critical patent/HRP20230677T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
HRP20230677TT 2019-07-09 2020-07-08 Kombinacija ibuprofena i tramadola za ublažavanje boli HRP20230677T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19382583 2019-07-09
EP20740266.0A EP3996699B1 (en) 2019-07-09 2020-07-08 Combination of ibuprofen and tramadol for relieving pain
PCT/EP2020/069306 WO2021005129A1 (en) 2019-07-09 2020-07-08 Combination of ibuprofen and tramadol for relieving pain

Publications (1)

Publication Number Publication Date
HRP20230677T1 true HRP20230677T1 (hr) 2023-10-13

Family

ID=67480112

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20230677TT HRP20230677T1 (hr) 2019-07-09 2020-07-08 Kombinacija ibuprofena i tramadola za ublažavanje boli

Country Status (21)

Country Link
US (1) US20220249414A1 (enExample)
EP (1) EP3996699B1 (enExample)
JP (1) JP7656339B2 (enExample)
CN (1) CN114080221B (enExample)
AU (1) AU2020309160B2 (enExample)
BR (1) BR112022000242A2 (enExample)
CA (1) CA3145632C (enExample)
DK (1) DK3996699T3 (enExample)
ES (1) ES2952013T3 (enExample)
FI (1) FI3996699T3 (enExample)
HR (1) HRP20230677T1 (enExample)
HU (1) HUE062529T2 (enExample)
MA (1) MA56341B1 (enExample)
MD (1) MD3996699T2 (enExample)
MX (1) MX2022000373A (enExample)
MY (1) MY207573A (enExample)
PL (1) PL3996699T3 (enExample)
PT (1) PT3996699T (enExample)
RS (1) RS64500B1 (enExample)
SI (1) SI3996699T1 (enExample)
WO (1) WO2021005129A1 (enExample)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US3652589A (en) 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
GB1497044A (en) 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5516803A (en) * 1991-10-30 1996-05-14 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US20070117826A1 (en) * 2005-11-23 2007-05-24 Forest Laboratories, Inc. Pharmaceutical formulations comprising ibuprofen, oxycodone, and 14-hydroxycodeinone
EP2149546A1 (en) * 2008-07-31 2010-02-03 Laboratorios Del. Dr. Esteve, S.A. Salts of tramadol and ibuprofen and their crystal form in the treatment of pain
ES2356762B1 (es) * 2009-09-04 2011-11-24 Farmalider S.A. Composicion farmaceutica de ibuprofeno, tramadol y un aminoacido basico, procedimiento para su preparacion y utilizacion de la misma.
ES2423866B1 (es) 2012-02-22 2014-06-10 Farmalider, S.A. Composición farmaceútica de ibuprofeno y tramadol para inyección
ES2540151B1 (es) * 2013-10-11 2016-02-29 Farmalider S.A. Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico
GB2541571A (en) * 2014-04-10 2017-02-22 Charleston Laboratories Inc Pharmaceutical compositions

Also Published As

Publication number Publication date
BR112022000242A2 (pt) 2022-05-31
MA56341B1 (fr) 2023-07-31
SI3996699T1 (sl) 2023-10-30
JP7656339B2 (ja) 2025-04-03
ES2952013T3 (es) 2023-10-26
EP3996699A1 (en) 2022-05-18
DK3996699T3 (da) 2023-07-24
MD3996699T2 (ro) 2023-11-30
CA3145632C (en) 2024-03-12
CN114080221B (zh) 2023-12-05
EP3996699B1 (en) 2023-06-28
MY207573A (en) 2025-03-05
PL3996699T3 (pl) 2023-10-30
HUE062529T2 (hu) 2023-11-28
RS64500B1 (sr) 2023-09-29
CA3145632A1 (en) 2021-01-14
PT3996699T (pt) 2023-07-27
JP2022540854A (ja) 2022-09-20
US20220249414A1 (en) 2022-08-11
MX2022000373A (es) 2022-02-10
WO2021005129A1 (en) 2021-01-14
AU2020309160A1 (en) 2022-02-17
CN114080221A (zh) 2022-02-22
AU2020309160B2 (en) 2025-06-26
FI3996699T3 (fi) 2023-08-01

Similar Documents

Publication Publication Date Title
JP2021066744A5 (ja) ブプロピオンおよびデキストロメトルファンを含む組成物
JP5395052B2 (ja) 炎症を処置するための組成物および方法
HRP20231613T1 (hr) Pripravci koji sadrže sredstvo za unošenje i njihova priprava
HRP20210034T1 (hr) Farmaceutski pripravci koji sadrže meloksikam i rizatriptan
HRP20231018T1 (hr) Terapeutski spojevi korisni za profilaktičko ili terapijsko liječenje hiv virusne infekcije
ME02179B (me) Metoda za lečenje atrijalne fibrilacije
DE60032749D1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin
HRP20241461T1 (hr) Aprocitentan za uporabu u liječenju hipertenzije i povezanih bolesti u kombinaciji s valsartanom
HRP20241213T1 (hr) Primjena sepiapterina bez hrane za uporabu u postupku za povećavanje plazmatske izloženosti sepiapterinu
HRP20241052T1 (hr) Semaglutid, namijenjen liječenju alzheimerove demencije
FI3577124T3 (fi) Nukleotidihemisulfaattisuola hepatiitti C -viruksen hoitoon
HRP20240501T1 (hr) Derivati pirido[2,3-d]pirimidina kao inhibitori replikacije virusa humane imunodeficijencije
HRP20250615T1 (hr) Tradipitant za upotrebu u liječenju gastropareze
HRP20251173T1 (hr) Triciklički parp1 inhibitori i njihove uporabe
HRP20231587T1 (hr) Kronično noćno doziranje lasmiditana radi sprječavanja migrene
HRP20221185T1 (hr) Beta-ukosnica peptidomimetik s inhibitorskom aktivnošću elastase i njegovi oblici doziranja aerosolom
JP2010524882A5 (enExample)
JP2011516544A5 (enExample)
JP2024061731A (ja) 片頭痛の予防及び治療に使用するための栄養補助食品
JP2005519936A5 (enExample)
CA2476939A1 (en) Pharmaceutical combinations of cox-2 inhibitors and opiates
HRP20211661T1 (hr) Igmezin, namijenjen upotrebi u liječenju alzheimerove bolesti
HRP20230677T1 (hr) Kombinacija ibuprofena i tramadola za ublažavanje boli
HRP20240703T1 (hr) Telmisartan za profilaksu ili liječenje hipertenzije kod mačaka
HRP20230735T1 (hr) Betahistin, ili njegova farmaceutski prihvatljiva sol, i inhibitor monoamin oksidaze, za uporabu u liječenju ili prevenciji jednog ili više simptoma vrtoglavice kod subjekta